We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · September 27, 2021

Estimated Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence

JAMA: The Journal of the American Medical Association


Additional Info

Disclosure statements are available on the authors' profiles:

JAMA: The Journal of the American Medical Association
Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021
JAMA 2021 Sep 02;[EPub Ahead of Print], JM Jones, M Stone, H Sulaeman, RV Fink, H Dave, ME Levy, C Di Germanio, V Green, E Notari, P Saa, BJ Biggerstaff, D Strauss, D Kessler, R Vassallo, R Reik, S Rossmann, M Destree, KA Nguyen, M Sayers, C Lough, DW Bougie, M Ritter, G Latoni, B Weales, S Sime, J Gorlin, NE Brown, CV Gould, K Berney, TJ Benoit, MJ Miller, D Freeman, D Kartik, AM Fry, E Azziz-Baumgartner, AJ Hall, A MacNeil, AV Gundlapalli, SV Basavaraju, SI Gerber, ME Patton, B Custer, P Williamson, G Simmons, NJ Thornburg, S Kleinman, SL Stramer, J Opsomer, MP Busch

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading